



Clinical Features and Diagnosis
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A B S T R A C T
Pulmonary embolism is a lethal yet treatable disease. Given the significant overlap 
of symptoms and signs between the presentation of pulmonary embolism and acute 
coronary syndromes, it becomes clear that emergency room physicians must be fami-
liar with the diagnosis of pulmonary embolism. A critical issue is always to consider 
pulmonary embolism in the differential diagnosis of chest pain. However, the clinical 
diagnosis of pulmonary embolism remains problematic due to the nonspecific pre-
senting symptoms, signs, electrocardiographic abnormalities, arterial blood gas and 
chest X-ray findings. D-dimers are becoming a widely available useful laboratory 
tool in the diagnosis of suspected pulmonary embolism. In this concise overview, the 
diagnostic value of clinical assessment in patients with possible pulmonary embolism 
will be explored.
Pulmonary embolism is responsible for 5-10% of all in-hospital deaths. Pulmonary 
embolism is an important diagnosis to establish, given that undiagnosed pulmonary 
embolism has a hospital mortality rate as high as 30%, which falls to nearly 8% if 
diagnosed and treated appropriately [1-3]. Unfortunately, however, the diagnosis of 
pulmonary embolism remains one of the most difficult problems. The main reason 
for this is that the clinical manifestations of pulmonary thromboembolism (Table 1) 
are non-specific, condition difficult to diagnose [2]. Indeed, pulmonary embolism is 
considered in the differential diagnosis of many clinical presentations including chest 
pain, hemoptysis and dyspnea. Less than 35% of patients suspected of having pulmo-
nary embolism actually have the diagnosis confirmed. Therefore, many patients without 
pulmonary embolism are needlessly hospitalized and anticoagulated while awaiting 
confirmatory testing [4-6]. Given the high mortality of untreated pulmonary embolism, 
timely diagnostic testing must be performed to enable the initiation of antithrombotic 
therapy for patients proven to have this condition while at the same time avoiding the 
risks of anticoagulation for patients in whom this diagnosis is excluded [4,7].
C L I N I C A L  P A R A M E T E R S  A N D  S Y M P T O M S
It is believed that diagnosis of pulmonary embolism is more difficult than treat-
ment. Additionally, for patients with pulmonary embolism the most treacherous period 
is that preceding the establishment of diagnosis. Clinical suspicion of this disease is 
of paramount importance in guiding diagnostic testing. Firstly, the patient’s age is 
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consistently a statistically significant univariate predictor for 
pulmonary embolism. Furthermore, the frequency of pulmo-
nary embolism among patients with a malignant neoplasm 
at necropsy is highly increased in elderly patients [3]. On 
the other hand, the patient’s gender does not appear to be 
predictive. Dyspnea, syncope or cyanosis indicate massive 
pulmonary embolism [8]. The lack of clinical manifestations 
of massive pulmonary embolism might be related to the insidi-
ous onset and progressive development of thromboembolism. 
However, the patient gradually adapts to and/or compensates 
for hemodynamic changes [9]. Contrariwise, pleuritic chest 
pain often signifies that the embolism is small and located in 
the distal pulmonary arterial system, near the pleural lining. 
In any event, individual presenting symptoms do not reliably 
differentiate between patients with and without pulmonary 
embolism. The exceptions in individual studies include pleu-
ritic chest pain and sudden dyspnea [10,11]. Leg symptoms 
are consistently more likely in patients who have pulmonary 
embolism. Hemoptysis is a rare presenting symptom in sus-
pected pulmonary embolism [11].
R I S K  F A C T O R S
Risk factors for venous thromboembolic disease (Table 2) 
are well characterized in the literature [8]. In patients treated 
for confirmed venous thromboembolic disease, one or more 
risk factors were present in over 96% of patients. Additionally, 
the presence of one or more risk factors was more common 
in patients with pulmonary embolism as opposed to those 
without pulmonary embolism. In patients with suspected pul-
monary embolism the only risk factors, which are consistently 
present more often in patients who are ultimately confirmed 
to have pulmonary embolism, are thromboembolic disease, 
malignancy, recent surgery and immobilization. However, 
only the last two factors reach statistical significance [6]. It 
is interesting to note that Medina et al [12] observed that in 
patients with primary antiphospholipid syndrome, the most 
frequent clinical manifestations were venous thrombosis, 
thrombocytopenia, and pulmonary thromboembolism.
C L I N I C A L  S I G N S
Patients with pulmonary embolism are more likely to be 
tachypneic and tachycardic than patients without pulmonary 
embolism. In the study of Hull et al6 there appears to be no 
difference in blood pressure, the presence of a pleural rub on 
auscultation or temperature in patients with confirmed and 
suspected pulmonary embolism. A commonly held misconcep-
tion is that the presence of chest wall tenderness in patients 
with pleuritic chest pain excludes pulmonary embolism. In one 
study the presence of a fourth heart sound, loud second pulmo-
nary heart sound and inspiratory crackles on chest ausculta-
tion were more common in patients with pulmonary embolism 
than in patients without pulmonary embolism [13].
D I F F E R E N T I A L  D I A G N O S I S
The differential diagnosis of pulmonary embolism remains 
extensive and covers a broad spectrum of life-threatening and 
other diseases (Table 3). Some patients have concomitant pul-
monary embolism and other diseases. Hence, we must, for 
example, take into account that if pneumonia or heart failure 
does not respond to appropriate therapy, the possibility of co-
existing pulmonary embolism should be considered. Discern-
ing between pulmonary embolism and primary pulmonary 
hypertension is of critical importance. Although both diseases 
warrant anticoagulation, other advances in management re-
quire differentiation between these two diseases [14].
Differential diagnosis in patients with massive pulmonary 




 Chest pain (pleuritic) 52%





 Tachypnea (>20/min) 70%
 Tachycardia (>100/min) 26%
 Signs of deep venous thrombosis 15%
 Fever (>38.5 °C) 7%
 Cyanosis 11%
TABLE 2. Risk factors for venous thromboembolism
Primary                                                
 Factor V Leiden                              Antithrombin III deficiency
 Resistance to activated protein C  Hyperhomocysteinemia
 Prothrombin 20210 mutation         Antiphospholipid antibodies
 Protein C deficiency                        Protein S deficiency
Secondary                                           
 Surgery/Immobilization/Trauma   Advanced age 
 Stroke/Spinal cord injury                Obesity
 Malignancy/Chemotherapy            Diabetes mellitus
 Heart failure                                    Smoking
 Pregnacy/puerperium                     Hypertension
 Central venous catheters                Oral contraceptives
 Chronic venous insufficiency         Long distance air travel
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embolism includes acute myocardial infarction, cardiac tam-
ponade and septic or other shock. On occasion, in patients 
without pulmonary infarction, presenting symptoms and signs 
may be attributed to anxiety with hyperventilation because of 
the paucity of objective pulmonary findings. When pulmonary 
infarction occurs, the differential diagnosis may include pneu-
monia, atelectasis, pericarditis, and heart failure.
E L E C T R O C A R D I O G R A P H I C  F I N D I N G S
A variety of electrocardiographic changes have been sug-
gested in several studies as having diagnostic value in patients 
with suspected pulmonary embolism [11,13,15,16]. However, 
these studies have one disadvantage relating to the fact that 
the investigators have only studied patients with confirmed 
pulmonary embolism. Rodger et al [16] found that tachycardia 
and incomplete right bundle branch block were significantly 
more frequent in patients with pulmonary embolism than in 
patients without pulmonary embolism. More recently, Sinha N 
et al [15] reported that sinus tachycardia, an S1/Q3/T3 pattern, 
atrial tachyarrhythmias, a Q wave in lead III, and a Q3/T3 
pattern were findings significantly associated with pulmonary 
embolism. These investigators [15] concluded that standard 
12-lead electrocardiographic changes can increase the pre-
test probability of pulmonary embolism before performing 
computed tomography (CT) pulmonary angiography, and 
that these electrocardiographic findings have relatively low 
likelihood to be of clinical use.
C H E S T  X - R A Y
Stein et al13 found that the most sensitive chest X-ray 
finding was atelectasis or parenchymal abnormality having 
a sensitivity of 68%. It is a fact, however, that one cannot 
depend on chest x-ray for the diagnosis of pulmonary embo-
lism [15]. Én one study, chest x-rays of patients with suspected 
pulmonary embolism were interpreted by radiologists who 
agreed on the presence of pulmonary embolism in only 33% 
of patients and among them in only 33% of patients was the 
diagnosis correct [17].
A R T E R I A L  B L O O D  G A S  A N A L Y S I S
One commonly held misconception is that a normal arte-
rial-alveolar gradient excludes pulmonary embolism [18], de-
spite reports to the contrary [19]. Stein et al [19] have proposed 
prediction rules based on arterial blood gas but these rules 
could not be validated in subsequent studies [20].
D - D I M E R
An abnormally elevated level of Elisa-determined plasma 
D-dimer has more than 90% sensitivity for identifying patients 
with pulmonary embolism proven by lung scan or by angio-
gram [21,22]. Én the study of Hammond and Hassan [23], 
retrospective analysis of a sequential series of 376 patients 
revealed that no patient with D-dimer of <275 ng/ml was 
diagnosed with pulmonary embolism, irrespective of clinical 
probability. Egermayer et al [24] showed that a negative D-
dimer, a paO2 of ≥80 mmHg and a respiratory rate less than 
20, also had a negative predictive value of 100% in patients 
with suspected pulmonary embolism. Rodger et al [25] were 
able to demonstrate a negative predictive value of 95% with 
this rule.
C L I N I C A L  P R E D I C T O R S
Despite the limitations of the individual clinical predic-
tors described by the PIOPED investigators [4], it has been 
demonstrated that the overall clinical assessment should guide 
diagnostic management. They were able to separate a cohort 
of patients with suspected pulmonary embolism into high-, 
moderate- and low-probability groups using clinical assess-
ment alone [25]. Perier et al [26] were also able to stratify 
patients into different risk categories using clinical assessment 
alone. In both of these studies patients were stratified into 
risk categories using the clinical judgment of the individual 
clinicians based on overall diagnostic impression alone. Ad-
ditionally, Wells et al [27] included in their study 1200 patients 
with suspected pulmonary embolism. These patients were 
separated based on clinical criteria, into low-, moderate-, 
and high-probability subgroups using the explicit clinical 










Costochondritis (Tietze’s syndrome) – Musculoskeletal pain
Intrathoracic cancer 
(Early) Herpes zoster
DaCosta syndrome (psychogenic pain)/Hyperventilation
Acute cholecystitis
Shock (cardiogenic, septic, hypovolemic)
Cardiac tamponade
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pulmonary embolism, while it provides valuable information 
about right ventricular function [32]. However, it is not widely 
available and experience is limited concerning diagnosis of 
pulmonary embolism. Venous ultrasonography is useful in de-
tecting proximal deep venous thrombosis which is a surrogate 
for pulmonary embolism. However, since a negative study can 
not rule out pulmonary embolism, its role is supplementary. 
Finally, standard pulmonary angiography has been considered 
the gold standard for the diagnosis of pulmonary embolism, 
but it is rarely performed since the advent of spiral chest CT 
scanning. At present, it is used when catheter-based interven-
tions are planned, such as catheter-directed thrombolysis or 
suction embolectomy.
Diagnostic procedures for pulmonary embolism continue 
to be refined and modalities such as spiral computer tomog-
raphy or magnetic resonance imaging have the potential to 
further increase the possibility of diagnosis of pulmonary 
embolism and thus obviate the need for pulmonary angi-
ography.
model. The prevalence of pulmonary embolism in the low-, 
moderate- and high-probability subgroups was 3%, 28%, and 
78%, respectively. In an attempt to simplify the explicit clini-
cal model, they subsequently performed a logistic regression 
analysis on clinical data collected in the aforementioned 
study. Their preliminary results have demonstrated that the 
simplified clinical model can separate patients into low-, 
moderate- and high-risk subgroups, although it appears that 
the emergency room physicians have a lower threshold for 
suspecting pulmonary embolism, so the overall pulmonary 
embolism rate was low in the validation study. Also, Miniati 
et al [28] reported the benefits of clinical assessment. Their 
combination of clinical predictors had a negative predictive 
value of 94% and pulmonary embolism could be excluded in 
42% of patients in their validation set.
D I A G N O S T I C  A L G O R I T H M
The diagnosis of acute pulmonary embolism is based on 
the assessment of factors, consistent symptoms and signs, and 
the lack of an alternative clinical explanation for the condi-
tion of the patient. If the probability of pulmonary embolism 
is low or intermediate, the diagnosis can be reliably excluded 
by a negative D-dimer test (Figure 1). A positive D-dimer test 
requires further evaluation with (perfusion and/or ventilation) 
lung scan or spiral computer tomography (CT) technique to 
confirm or rule out pulmonary embolism [29].
I M A G I N G  M O D A L I T I E S
Imaging modalities have a significant role, beyond 
standard clinical assessment, in the diagnosis of pulmonary 
embolism and decision making thereafter. Spiral chest CT 
is currently preferred over pulmonary radionuclide perfu-
sion (and/or ventilation) scintigraphy as the initial imaging 
test. First generation CT scanners had a sensitivity of 70% 
compared to pulmonary angiography [30]. However, latest 
generation multidetector-row CT scanners have excellent 
resolution and are likely to supplant pulmonary angiography 
as the gold standard imaging study. Pulmonary radionuclide 
perfusion (and/or ventilation) scintigraphy is at present a se-
cond choice test, reserved for patients with contrast allergy, 
renal insufficiency or pregnant women (lower radiation dose 
for fetus compared to spiral chest CT). Echocardiography is a 
useful, rapid, bedside modality with a major role to detect right 
ventricular dysfunction or dilation, and thus guide therapy, 
particularly in the case of massive pulmonary embolism 
when in need for thrombolytic treatment. It is, therefore, not 
a routine diagnostic test but it contributes to risk stratification, 
prognosis and therapeutic decision making [31]. Magnetic reso-
nance imaging is sensitive and specific for segmental or larger 
FIGURE 1. Diagnostic algorithm for suspected non-massive pul-
monary embolism. CT indicates computed tomography.
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